These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 19233912)

  • 21. The first Japanese case of familial porphyria cutanea tarda diagnosed by a UROD mutation.
    Matsui A; Akasaka E; Rokunohe D; Matsuzaki Y; Sawamura D; Nakano H
    J Dermatol Sci; 2019 Jan; 93(1):65-67. PubMed ID: 30522880
    [No Abstract]   [Full Text] [Related]  

  • 22. Familial and sporadic porphyria cutanea tarda: clinical, biochemical and genetic features with emphasis on iron status.
    Bygum A; Christiansen L; Petersen NE; Hørder M; Thomsen K; Brandrup F
    Acta Derm Venereol; 2003; 83(2):115-20. PubMed ID: 12735639
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Mutations of hemochromatosis gene in volunteer blood donors and Chilean porphyria cutanea tarda patients].
    Wolff CF; Armas RM; Frank J; Poblete PG
    Medicina (B Aires); 2006; 66(5):421-6. PubMed ID: 17137171
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Longitudinal study of a mouse model of familial porphyria cutanea tarda.
    Arch DD; Bergeron M; Hathaway L; Kushner JP; Phillips JD; Franklin MR
    Cell Mol Biol (Noisy-le-grand); 2009 Jul; 55(2):46-54. PubMed ID: 19656451
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Pathogenesis of porphyria cutanea tarda].
    Kószó F; Simon M
    Orv Hetil; 2000 Apr; 141(14):709-13. PubMed ID: 10803012
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Sporadic porphyria cutanea tarda due to haemochromatosis.
    de Geus HR; Dees A
    Neth J Med; 2006 Sep; 64(8):307-9. PubMed ID: 16990695
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Familial and sporadic porphyria cutanea tarda: clinical and biochemical features and risk factors in 152 patients.
    Muñoz-Santos C; Guilabert A; Moreno N; To-Figueras J; Badenas C; Darwich E; Herrero C
    Medicine (Baltimore); 2010 Mar; 89(2):69-74. PubMed ID: 20517178
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Seven novel point mutations in the uroporphyrinogen decarboxylase (UROD) gene in patients with familial porphyria cutanea tarda (f-PCT).
    Cappellini MD; Martinez di Montemuros F; Tavazzi D; Fargion S; Pizzuti A; Comino A; Cainelli T; Fiorelli G
    Hum Mutat; 2001 Apr; 17(4):350. PubMed ID: 11295834
    [TBL] [Abstract][Full Text] [Related]  

  • 29. High prevalence of the His63Asp HFE mutation in Italian patients with porphyria cutanea tarda.
    Sampietro M; Piperno A; Lupica L; Arosio C; Vergani A; Corbetta N; Malosio I; Mattioli M; Fracanzani AL; Cappellini MD; Fiorelli G; Fargion S
    Hepatology; 1998 Jan; 27(1):181-4. PubMed ID: 9425935
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Porphyria cutanea tarda: Recent update.
    Singal AK
    Mol Genet Metab; 2019 Nov; 128(3):271-281. PubMed ID: 30683557
    [TBL] [Abstract][Full Text] [Related]  

  • 31. HFE mutations and transferrin receptor polymorphism analysis in porphyria cutanea tarda: a prospective study of 36 cases from southern France.
    Dereure O; Aguilar-Martinez P; Bessis D; Perney P; Vallat C; Guillot B; Blanc F; Guilhou JJ
    Br J Dermatol; 2001 Mar; 144(3):533-9. PubMed ID: 11260010
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The role of inherited and acquired factors in the development of porphyria cutanea tarda in the Argentinean population.
    Méndez M; Rossetti MV; Del C Batlle AM; Parera VE
    J Am Acad Dermatol; 2005 Mar; 52(3 Pt 1):417-24. PubMed ID: 15761419
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Identification and characterization of novel uroporphyrinogen decarboxylase gene mutations in a large series of porphyria cutanea tarda patients and relatives.
    Badenas C; To-Figueras J; Phillips JD; Warby CA; Muñoz C; Herrero C
    Clin Genet; 2009 Apr; 75(4):346-53. PubMed ID: 19419417
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A mutation (G281E) of the human uroporphyrinogen decarboxylase gene causes both hepatoerythropoietic porphyria and overt familial porphyria cutanea tarda: biochemical and genetic studies on Spanish patients.
    Roberts AG; Elder GH; De Salamanca RE; Herrero C; Lecha M; Mascaro JM
    J Invest Dermatol; 1995 Apr; 104(4):500-2. PubMed ID: 7706766
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The prevalence of HFE C282Y gene mutation is increased in Spanish patients with porphyria cutanea tarda without hepatitis C virus infection.
    Toll A; Celis R; Ozalla MD; Bruguera M; Herrero C; Ercilla MG
    J Eur Acad Dermatol Venereol; 2006 Nov; 20(10):1201-6. PubMed ID: 17062032
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [59-year-old patient with cutaneous lesions and increased iron metabolism parameters].
    Mangold E; Diepolder H; Lohse P; Pape GR; Ritter MM
    Internist (Berl); 2000 Oct; 41(10):1103-7. PubMed ID: 11084896
    [No Abstract]   [Full Text] [Related]  

  • 37. Association of porphyria cutanea tarda with hereditary hemochromatosis.
    Mehrany K; Drage LA; Brandhagen DJ; Pittelkow MR
    J Am Acad Dermatol; 2004 Aug; 51(2):205-11. PubMed ID: 15280838
    [TBL] [Abstract][Full Text] [Related]  

  • 38. CYP1A2*1F and GSTM1 alleles are associated with susceptibility to porphyria cutanea tarda.
    Wickliffe JK; Abdel-Rahman SZ; Lee C; Kormos-Hallberg C; Sood G; Rondelli CM; Grady JJ; Desnick RJ; Anderson KE
    Mol Med; 2011; 17(3-4):241-7. PubMed ID: 20957336
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Familial porphyria cutanea tarda: characterization of seven novel uroporphyrinogen decarboxylase mutations and frequency of common hemochromatosis alleles.
    Mendez M; Sorkin L; Rossetti MV; Astrin KH; del C Batlle AM; Parera VE; Aizencang G; Desnick RJ
    Am J Hum Genet; 1998 Nov; 63(5):1363-75. PubMed ID: 9792863
    [TBL] [Abstract][Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.